Board of Directors
Erik Giphart, PhD
Erik Giphart is an experienced CTO and R&D manager with 20+ years of progressive experience in scientific research, medical device design and development, as well as program and business management. He has a proven ability to provide vision, as well as strategic and technical leadership for innovation and research activities. Erik has a master’s degree in Electrical Engineering from Delft University of Technology, Delft, the Netherlands, specializing in Information Theory (1994), and a PhD in Biomedical Engineering from Boston University (2001).
show moreHe spent most of his academic career studying biomechanics, building advanced research environments such as a Virtual Reality Lab and a BioMotion Lab which included a 1000 fr/s stereo x-ray imaging system, publishing 30+ peer reviewed articles in both well-known engineering and clinical journals along the way. After a working at Boston University and at the Steadman Philippon Research Institute in Vail, Colorado, in research capacities, he switched to the medical device industry in 2012.
Erik joined Halifax Biomedical Inc (HBI) in Canada, a start-up company commercializing stereo x-ray technology, serving as Director of Engineering and CTO shortly. He directed two major programs involving the development of surgical instrumentation, static and dynamic stereo x-ray equipment, advanced 3D image analysis software, a tele-radiology framework for image analysis, and a mobile imaging trailer. Upon his return to Colorado, Erik joined Evergreen Research Inc, as Director of Engineering which introduced him to ArcScan. Erik previously served as ArcScan’s VP of Engineering, he developed the Engineering function within ArcScan and brought all R&D activities in-house.
show less
Dr. Zhaoxing Dai, MD
Dr. Zhaoxing Dai, is a distinguished medical professional with a robust background in ophthalmology, medical device innovation, and healthcare leadership. A holder of a Doctorate in Clinical Medicine from Fudan University, Dr. Dai has over a decade of clinical and research experience, coupled with exceptional expertise in the development and commercialization of ophthalmic technologies.
show moreDr. Dai is renowned for his proficiency in diagnosing and treating common ophthalmic diseases, with a particular specialization in anterior segment surgeries such as cataract and glaucoma procedures. His surgical precision and commitment to patient care earned him recognition as the “Excellent Resident of the Year” during his tenure at the Eye-ENT Hospital of Fudan University. In 2018, he was certified as an attending ophthalmologist by the National Health Commission of China.
Dr. Dai has been honored as a **Shanghai Songjiang G60 Outstanding Talent** and a recipient of the **Shanghai Science and Technology Commission Rising Star Talent Award**. He has successfully led teams in high-impact roles, including his current position as Chief at the Shanghai Meishi Ophthalmic & Optics Research Institute. There, he spearheads real-world studies to advance eye care and contributes to breakthroughs in medical technology.
As the Managing Director and CEO of Zhejiang Eyexpert Meditech, Dr. Dai played a pivotal role in registering three innovative medical devices, solidifying the company’s position in the ophthalmic market. He also led strategic marketing initiatives for Haohai Biological Technology, driving international growth through successful acquisitions in the U.S., U.K., and China.
Dr. Dai has been actively involved in several high-impact research projects supported by Fudan University, the Shanghai Science and Technology Commission, and the Shanghai Health Commission. His findings have been published in seven leading peer-reviewed journals, amassing a cumulative impact factor exceeding 20. He holds multiple national invention patents, underscoring his innovative contributions to ophthalmic medical devices. Dr. Dai’s career is marked by his dedication to bridging clinical practice with technological advancement. His expertise in ophthalmology, combined with his strategic leadership and innovative approach to medical device development, continues to shape the future of ocular health.
show less
Loren Brown
Loren Brown is president of Vance Brown and Associates, a San Francisco Bay area firm established in 1932. Brown is a third generation relative of the founder, Vance Meacham Brown. The company has extensive experience in a variety of construction improvements for a multitude of owners, architects, and tenants in many different municipalities.
show moreThe firm has constructed many projects at Stanford University, as well as private school buildings, biotech laboratories, clean rooms, senior housing projects, restaurants, and warehouses. Notable projects include the Stanford tennis and football stadiums, Quantum Corporate Headquarters, The Hamilton, Evvia Restaurant, Tully’s Coffee, ALZA Corporate Headquarters, Westport Office Park, as well as Stanford University’s Arillaga Family Sports Center, Alumni Center, and Boathouse.
show less
Dan Reinstein, MD
Dr. Dan Reinstein MD was appointed Chief Medical Officer in May 2015 but he has been acting as lead clinical consultant for many years. He is the founder and current Medical Director of the London Vision Clinic in the United Kingdom and also serves as Adjunct Professor of Ophthalmology at Columbia University Medical Center, New York, and Professeur Associé en Ophtalmologie at the Centre Hospitalier National d’Ophthalmologie des Quinzes Vingts, Paris.
show moreProfessor Reinstein, MD, received his undergraduate degree from Cambridge University and his postgraduate training in medicine at Cambridge University School of Medicine. He conducted his internship in medicine at the University College London School of Medicine, University of London. Dr. Reinstein MD. Then spent several years at the Weill Medical College of Cornell University in New York as a Bioengineering Fellow, developing very high-frequency (VHF) digital ultrasound technology (Artemis) for studying the micro-anatomical structure of the cornea in vivo.
Professor Reinstein’s research focuses on applications of the preliminary Insight® 100 technology to improve excimer corneal and phakic intraocular refractive surgery with a focus on measurement of the corneal epithelium for applications such as keratoconus screening and therapeutic corneal refractive surgery. His research has led to over 115 peer-reviewed publications, 30 book chapters and 500 international presentations and lectures. He was awarded the Waring Medal in 2006 and received the Kritzinger Award in 2013. Professor Reinstein holds over 10 patents in the field of laser eye surgery and ultrasound diagnostic imaging and signal processing.
show less
Roger Sun, MD, MBA
Roger Sun has over 25 years of experience in business development, venture development and investment, corporate strategy and planning, alliance/partnership management, portfolio management, new product development, marketing strategy and clinical practice from various roles in biotechnology industry. Dr. Sun is the CEO and founder of Simedice Biotechnologies, Inc. which develops, manufactures, and markets high-end hydrophobic intraocular lens products including trifocal lens, trifocal toric lens and EDOF lens to treat global cataract patients.
show morePrior to Simedice, Dr. Sun was an investment director of Baxter Ventures in Baxter Healthcare Corporation to directly work with innovative biotechnology startups from concepts to marketed better medical products and eventual company IPOs. Prior to Baxter, Dr. Sun worked in the business development group of Bayer Healthcare Corporation to establish and manage business partnerships such as technology in-licensing and company acquisitions. Dr. Sun received his MD in ophthalmology from Peking University Medical Science Center and his MBA in finance and entrepreneurship from Kelly School of Business in Indiana University at Bloomington. Dr. Sun has published more than 20 scientific papers in peer-reviewed international scientific journals.
show less
Dr. Robert Lin
Director
Dr. Robert Lin, Founder and CEO of IQ Laser Vision, received his undergraduate education from UC Berkeley and medical training at UCLA. He completed his residency at the Jules Stein Eye Institute at UCLA, one of the world’s most preeminent programs, where he is currently an Assistant Clinical Professor.
show moreDr. Lin has successfully performed more than 70,000 refractive procedures over the past 25 years. As one of California’s most experienced eye surgeons, he believes in the importance of personalized care and takes pride in developing a genuine relationship by treating each patient like family.
Dr. Lin has been the medical director, chief surgeon, and CEO of IQ Laser Vision for 20 years, and with the addition of 7 other surgeons, Dr. Lin now performs only 15% of the surgeries, so he can focus on the expansion and profitability of the company.
He is also an international trainer and practice consultant for SMILE (Zeiss) and EVO ICL (Staar) and has facilitated many partnerships and joint ventures.
show less
Peter M. Ballachey, CPA-CA, CIA
Secretary and Chief Financial Officer
Peter is meticulous, organized and strategic in his thinking and was formally appointed as ArcScan’s CFO in 2015. His expertise in finance and accounting is considerable with experience as Board Director, CFO and financial consultant. He is also an officer and co-founder of CRC Rail Management Services Ltd, as well as Director and Chief Financial Officer of Tractive Power Corporation.
show morePeter served as Chief Financial Officer of Underground Energy Inc. Peter is meticulous, organized, and strategic in his thinking. His expertise in finance/accounting is considerable and ideally applicable for organizations such as ArcScan.
show less